Samsung Bioepis receives Brazilian approval for Brenzys®

Sep 10, 2019

Samsung Bioepis announces Brazilian approval for Brenzys®. For the first 10 years, Samsung Bioepis willl supply the drug to local distributors, during which a technology transfer with local partners will take place, allowing local partners to take over manufacturing after this period.

Print Page Mail Article